| 英文别名 |
6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-2-hydroxy-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]pyrimidine-4-carboxamide;GSK 3326595;GSK-3326595;GSK3326595;(S)-6-((1-acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide;VXT8SZ6875;JLCCNYVTIWRPIZ-NRFANRHFSA-N;BDBM178166;EPZ015938;SB19657;GSK3326595(EPZ015938);A16862;US9675614, 208;6-[(1-Acetylpiperidin-4-yl)amino]-N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]pyrimi;6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide;BCP25738;NSC80;CS-6451;NSC-800404;(S)-6-(1-Acetylpiperidin-4-ylamino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide;6-((1-ACETYL-4-PIPERIDINYL)AMINO)-N-((2S)-3-(3,4-DIHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXYPROPYL)-4-PYRIMIDINECARBOXAMIDE;EPZ-015938;GSK3326595?;PEMRAMETOSTAT [INN];6-((1-acetyl-4-piperidinyl)amino)-N-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl)-4-pyrimidinecarboxamide;CHEMBL4466233;EPZ015938; GSK-3326595;PEMRAMETOSTAT [WHO-DD];Pemrametostat;C24H32N6O3;P16134;MFCD29991177;DB-213221;s8664;NSC800404;4-pyrimidinecarboxamide, 6-((1-acetyl-4-piperidinyl)amino)-N-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl)-;SCHEMBL15825290;GSK 3326595; GSK3326595; EPZ015938; EPZ 015938; EPZ-015938;1616392-22-3;GSK3326595 (EPZ015938);4-PYRIMIDINECARBOXAMIDE, 6-((1-ACETYL-4-PIPERIDINYL)AMINO)-N-((2S)-3-(3,4-DIHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXYPROPYL)-;EPZ015938(pemrametostat)?;PROTEIN ARGININE METHYLTRANSFERASE 5 INHIBITOR GSK3326595;PRMT5 Inhibitor GSK3326595;Gsk 3326595;UNII-VXT8SZ6875;EN300-7445463;CCG-269258;GSK-3326595A;AS-53150;AKOS030528008;HY-101563 |